Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogens, migraine, and stroke.

Marie-Germaine Bousser1

  • 1Department of Neurology, Lariboisière Hospital, 2 Rue Ambroise Paré, Paris Cédex 10, France 75571. mg.bousser@lrb.ap-hop-paris.fr

Stroke
|October 2, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of blood pressure-lowering agents on microvascular function in people with small vessel diseases (TREAT-SVDs): a multicentre, open-label, randomised, crossover trial.

The Lancet. Neurology·2023
Same author

The EffecTs of Amlodipine and other Blood PREssure Lowering Agents on Microvascular FuncTion in Small Vessel Diseases (TREAT-SVDs) trial: Study protocol for a randomised crossover trial.

European stroke journal·2023
Same author

Effect of Endovascular Treatment With Medical Management vs Standard Care on Severe Cerebral Venous Thrombosis: The TO-ACT Randomized Clinical Trial.

JAMA neurology·2020
Same author

Labbé vein thrombosis.

Neuroradiology·2020
Same author

Long-Term Outcomes After Reversible Cerebral Vasoconstriction Syndrome.

Stroke·2019
Same author

Non-cardioembolic stroke/transient ischaemic attack in Asians and non-Asians: A post-hoc analysis of the PERFORM study.

European stroke journal·2019
Same journal

Defining the Therapeutic Ceiling of Endovascular Thrombectomy in Large-Core Stroke: Beyond the Limits of ASPECTS.

Stroke·2026
Same journal

Adjunctive Normobaric Hyperoxia With Endovascular Thrombectomy for Acute Stroke at 6 to 24 Hours: A Phase IIb Randomized Trial.

Stroke·2026
Same journal

Management of Patients at Risk of Ischemic Stroke With Left Ventricular Systolic Dysfunction in the Absence of Intracardiac Thrombus: A Scientific Statement From the American Heart Association.

Stroke·2026
Same journal

Update on Rehabilitation After Stroke: Global Changes and the Continued Importance of Therapy Intensity, Dose, and Timing.

Stroke·2026
Same journal

ENTF Neuromodulation Yields Reduced Disability After Stroke: An Individual Participant-Level Data Meta-Analysis.

Stroke·2026
Same journal

Menopause and Its Implications for Stroke in Women.

Stroke·2026
See all related articles

Estrogen influences migraine frequency in women, and migraine with aura increases stroke risk. While oral contraceptives are generally safe for young migraineurs, avoiding smoking and using low-estrogen options is recommended, especially for those with aura.

Area of Science:

  • Neurology
  • Endocrinology
  • Epidemiology

Background:

  • Estrogens significantly impact migraine prevalence and presentation in women, particularly around puberty, menstruation, and pregnancy.
  • Migraine, especially with aura, is a recognized risk factor for ischemic stroke in women.
  • The underlying pathophysiological mechanisms linking estrogens, migraine, and stroke remain largely unelucidated.

Purpose of the Study:

  • To explore the complex interplay between estrogens, migraine, and stroke risk in premenopausal women.
  • To provide practical recommendations for managing oral contraceptive use in female migraineurs.

Main Methods:

  • Review of epidemiological studies and clinical observations.
  • Analysis of risk factors associated with migraine and stroke.

Related Experiment Videos

Main Results:

  • Estrogen's influence on migraine is evident in its hormonal fluctuations (puberty, menstruation, pregnancy).
  • Migraine with aura confers a 3-fold increased risk of ischemic stroke, further elevated by smoking and oral contraceptive use.
  • The absolute stroke risk in young women is low, suggesting no absolute contraindication for oral contraceptives.

Conclusions:

  • Careful consideration of hormonal factors is crucial in managing migraine in women.
  • For young female migraineurs, particularly those with aura, recommendations include smoking cessation and preference for low-estrogen oral contraceptives or progestogen-only options.
  • Further research is needed to understand the precise pathophysiological links between estrogens, migraine, and stroke.